Could stem cells help COVID-19 patients breathe again?
NCT ID NCT04615429
First seen Mar 29, 2026 · Last updated May 21, 2026 · Updated 9 times
Summary
This study tested a one-time infusion of stem cells (mesenchymal stromal cells) in 20 adults with severe lung failure caused by COVID-19. The goal was to see if the treatment improved oxygen levels within a week compared to a placebo. The trial is complete, but results are not yet published.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Universitario Puerta de Hierro-Majadahonda
Majadahonda, Madrid, 28222, Spain
Conditions
Explore the condition pages connected to this study.